| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Other Original Articles |
Divisions of Pediatric Endocrinology (J.-M.V., J.D., G.G., P.E.M.) and Molecular Human Genetic (S.G.), University Childrens Hospital, 3010 Bern, Switzerland; and Dokuz Eylül Faculty of Medicine (A.B., P.C.), 35340 Izmir, Turkey
Address all correspondence and requests for reprints to: Prof. Dr. Primus E. Mullis, Division of Pediatric Endocrinology, University Childrens Hospital, CH-3010 Bern, Switzerland. E-mail: primus.mullis{at}insel.ch
Abstract
We identified a new nonsense mutation of the TSH-ß
subunit gene responsible for a severe isolated TSH deficiency
in two children from the same consanguineous kindred. These affected
children are homozygous for a C-to-T transition at nucleotide 654 of
the TSH-ß subunit gene, leading to the conversion of a
glutamine (CAG) to a premature stop codon
(TAG) in the codon 49 (Q49X). The resulting nascent
peptide does not contain the seat belt region (amino acid residues
88105), a TSH-ß subunit region crucial for the dimerization with
the
-subunit, and, hence, the correct secretion of the mature TSH
heterodimer is hampered. Free T3, free T4 as
well as basal TSH levels were extremely low in both affected
individuals and, importantly, TRH stimulations failed to increase serum
TSH, but not PRL, confirming isolated TSH deficiency. Using the new
StyI endonuclease restriction site generated by the
mutation, we confirmed that the affected children were homozygous for
the Q49X TSH-ß mutation whereas their unaffected parents as well as
their unaffected brother were heterozygous. Consequently, this isolated
TSH deficiency follows an autosomal recessive mode of
inheritance.
This article has been cited by other articles:
![]() |
G. Borck, A. K. Topaloglu, E. Korsch, U. Martine, G. Wildhardt, N. Onenli-Mungan, B. Yuksel, U. Aumann, G. Koch, G. Ozer, et al. Four New Cases of Congenital Secondary Hypothyroidism due to a Splice Site Mutation in the Thyrotropin-{beta} Gene: Phenotypic Variability and Founder Effect J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 4136 - 4141. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |